Sale!

Neuromuscular Panel NGS Genetic Test

4,400 د.إ

-27%

The Neuromuscular Panel NGS (Next Generation Sequencing) Genetic Test, offered at DNA Labs UAE for a cost of 4400 AED, is a comprehensive diagnostic tool designed to identify genetic mutations associated with various neuromuscular disorders. This state-of-the-art testing panel utilizes next-generation sequencing technology to analyze multiple genes simultaneously, providing a highly accurate and efficient method for detecting genetic variations that could lead to conditions such as muscular dystrophies, neuropathies, myopathies, and motor neuron diseases.

By targeting the genetic underpinnings of these disorders, the Neuromuscular Panel NGS Genetic Test aids in the early diagnosis, management, and treatment planning for patients exhibiting symptoms or having a family history of neuromuscular conditions. The test is conducted in the sophisticated laboratories of DNA Labs UAE, ensuring high standards of accuracy, reliability, and confidentiality in the genetic analysis and reporting process. With a cost of 4400 AED, this genetic test is a valuable investment for individuals seeking insights into their genetic predisposition to neuromuscular diseases, ultimately facilitating better health outcomes through personalized medical care.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

Neuromuscular Panel NGS Genetic Test

Test Name: Neuromuscular panel NGS Genetic DNA Test

Components Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for Neuromuscular panel NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Neuromuscular panel

Test Details

The neuromuscular panel NGS genetic DNA test is a type of genetic testing that uses next-generation sequencing (NGS) technology to analyze genes related to neuromuscular disorders. This test can identify mutations or variations in genes that are associated with a wide range of neuromuscular conditions, including muscular dystrophies, myopathies, and neuropathies.

The test typically involves collecting a sample of DNA from the patient, which can be obtained through a blood or saliva sample. The DNA is then analyzed using NGS technology to sequence the patient’s genes and identify any mutations or variations that may be relevant to neuromuscular disorders.

The results of the test can provide valuable information about a patient’s risk for developing a neuromuscular disorder, as well as potential treatment options and prognosis. This information can be used to guide clinical decision-making and help patients and their families make informed choices about their healthcare.

 

Test NameNeuromuscular panel NGS Genetic DNA Test
Components 
Price4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeNeurological Disorders
DoctorNeurologist
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for Neuromuscular panel NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Neuromuscular panel
Test Details

The neuromuscular panel NGS genetic DNA test is a type of genetic testing that uses next-generation sequencing (NGS) technology to analyze genes related to neuromuscular disorders. This test can identify mutations or variations in genes that are associated with a wide range of neuromuscular conditions, including muscular dystrophies, myopathies, and neuropathies.

The test typically involves collecting a sample of DNA from the patient, which can be obtained through a blood or saliva sample. The DNA is then analyzed using NGS technology to sequence the patient’s genes and identify any mutations or variations that may be relevant to neuromuscular disorders.

The results of the test can provide valuable information about a patient’s risk for developing a neuromuscular disorder, as well as potential treatment options and prognosis. This information can be used to guide clinical decision-making and help patients and their families make informed choices about their healthcare.